Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.16 USD | -0.42% | +3.38% | -12.20% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
- Stock Market
- Equities
- URGN Stock
- News UroGen Pharma Ltd.
- Analyst Reco.